Mark Douglas Smith, Director at Jazz Pharmaceuticals plc (JAZZ), sold 834 shares at $121.30 ($101K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
Open-market sale of $101k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.30 | 417 | $51K | 50.0% |
| 2 | $121.30 | 417 | $51K | 50.0% |
| Total | $121.30 avg | 834 | $101K | 100% |
| Filing → |
| TDOC | BUY | 2024-08-19 | $28K | — | Filing → |
| PHR | SELL | 2024-07-22 | $175K | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |